Literature DB >> 18795652

Clinicopathologic study of resected cases of primary carcinoma of the cystic duct.

Kensuke Kubota1, Yukio Kakuta, Yoshiaki Inayama, Masato Yoneda, Yasunobu Abe, Masahiko Inamori, Hiroyuki Kirikoshi, Satoru Saito, Atsushi Nakajima, Kazuya Sugimori, Kenichi Matuo, Takeda Kazunaga, Hiroshi Shimada.   

Abstract

BACKGROUND/AIMS: There have been few reports of primary carcinoma of the cystic duct (CCD) included in advanced cases. The aim of this study was to elucidate the clinical features of resected CCD.
METHODOLOGY: Six cases of CCD were diagnosed in which the main carcinomatous component arose from the cystic bile duct, even if these carcinomas were accompanied by invasion beyond the cystic duct. Histopathologic findings (i.e., H.E. staining and cell proliferating potency assessed by ki-67 staining) were compared between the main lesion and invasive lesion of the CCD.
RESULTS: Abdominal ultrasonography revealed swelling of the gallbladder in 3 of the 6 patients, but not in the remaining 3, who were later diagnosed as having adenomyomatosis of the gallbladder, dystelectasis due to the carcinomatous infiltration, and atrophic gallbladder, respectively. On computed tomography, 4 of the 6 cases with nodular-type lesions fulfilling Farrar's criteria, the tumors showed contrast enhancement. Direct cholangiography demonstrated unilateral obstruction of the common bile duct in 4 out of the 6 cases. Intraductal ultrasonography revealed CCD in only 1 of the 6 cases. Advanced CCD shows 2 patterns of invasion; the hepatic hilum pattern and the confluence invasive pattern. The hepatic hilum pattern of invasion tends to be associated with a poorer prognosis. Histopathological study revealed papillary and/or well differentiated adenocarcinoma in the cases where the lesion predominantly involved the cystic duct, whereas those lesions which extended beyond the cystic duct were composed of moderate and/or poorly differentiated tubular adenocarcinoma. The latter was associated with a high cellular proliferative activity as assessed by immunocytochemical examination for ki-67. Invasion of the perineural space was often observed in the cases with advanced CCD.
CONCLUSIONS: CCD showed the hepatic hilum and/or confluence pattern of invasion when the tumor extended beyond the cystic duct. CCD extending beyond the cystic duct was associated with more aggressive characteristics of the tumors, with perineural infiltration and histopathologic features resembling those of pancreatic cancer. It is concluded that CCDs extending beyond the cystic duct are more aggressive and associated with a poorer prognosis.

Entities:  

Mesh:

Year:  2008        PMID: 18795652

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  5 in total

1.  Preoperative diagnosis of early cystic duct cancer using endoscopic ultrasonography and endocholangioscopy: report of a case.

Authors:  Hiroaki Shiba; Takeyuki Misawa; Ryusuke Ito; Hiroo Imazu; Masafumi Suzuki; Katsuhiko Yanaga
Journal:  J Gastrointest Surg       Date:  2011-04-22       Impact factor: 3.452

Review 2.  Primary carcinoma of the cystic duct: a case report and review of classifications.

Authors:  Lovenish Bains; Daljit Kaur; Arun Kumar Kakar; Aman Batish; Seema Rao
Journal:  World J Surg Oncol       Date:  2017-01-19       Impact factor: 2.754

3.  Cystic duct cancer: Should it be deemed as a type of gallbladder cancer?

Authors:  Tu-Nan Yu; Ying-Ying Mao; Fang-Qiang Wei; Hui Liu
Journal:  World J Gastroenterol       Date:  2019-11-28       Impact factor: 5.742

4.  Early Detection of High-grade Biliary Intraepithelial Neoplasia (BilIN-3) in the Cystic Duct Visualized by SpyGlass DS Cholangioscopy.

Authors:  Katsuyuki Miyabe; Kenji Notohara; Go Asano; Akihisa Kato; Naruomi Jinno; Makoto Natsume; Yasuki Hori; Michihiro Yoshida; Itaru Naitoh; Ken Tsuboi; Yoichi Matsuo; Hirotaka Ohara; Kazuki Hayashi; Hiromi Kataoka
Journal:  Intern Med       Date:  2020-09-05       Impact factor: 1.271

5.  Cystic Duct Carcinoma: A New Classification System and the Clinicopathological Features of 62 Patients.

Authors:  Lingxi Nan; Changcheng Wang; Yajie Dai; Jie Wang; Xiaobo Bo; Shulong Zhang; Dexiang Zhang; Houbao Liu; Yueqi Wang
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.